The session provides practical updates and resources for researchers and developers advancing stem cell–based therapies. Speakers will highlight a new publication on Intellectual Property (IP) considerations in PSC therapy development, introduce a CDMO directory available to ISSCR members, and share key regulatory insights from recent meetings with global regulatory agencies.
Speaker:
- Allison Glasunow, PhD, Partner, Sheppard